Stanford
http://www.stanfordgroup.com/#Stanford provides institutional investment services and private wealth management services. The firm also offers equity research to its clients in the consumer, media, energy, financial, healthcare, technology and water/environment sectors.
View Older Stories View More Recent Stories
-
Just Energy Group (JE) Appoints Walter M. Higgins III to Board
-
Which 2019 College Football Home Opener has the Cheapest Tickets?
-
Top 33 College Football Games of 2019
-
Top 33 College Football Games of 2019
-
EyePoint Pharmaceuticals (EYPT) Highlights Positive Data Showcasing YUTIQ at 2019 ASRS Meetings
-
Public Storage (PSA) Announces Tariq M. Shaukat to Board
-
Intuitive Surgical (ISRG) Names Amy L. Ladd MD to Board
-
Simply Good Foods (SMPL) Announces James D. White to Board
-
StarTek (SRT) Names Rajiv Ahuja as Global COO
-
Opera Limited (OPRA) Names James Liu to Board
-
Stanford Health Care and Sutter Health sign letter of intent to explore opportunities to enhance care and improve choice for oncology patients in the East Bay
-
Stanford Health Care and Sutter Health sign letter of intent to explore opportunities to enhance care and improve choice for oncology patients in the East Bay
-
Translate Bio (TBIO) Names George Demetri MD to Board
-
Harvard Bioscience (HBIO) Names James Green President and CEO
-
Luxfer Declares Quarterly Dividend and Announces Date of Second Quarter Earnings Release
-
TG Therapeutics (TGTX) Provides Long-Term Follow-Up Data from Phase 2 Trial of Ublituximab in Patients with MS
-
Mirati Therapeutics (MRTX) Names Dr. Julie Cherrington to Board
-
Regions Financial (RF) Announces Organizational Changes
-
Yum! Brands (YUM) Names Chris Turner as CFO
-
Corelogic (CLGX) Appoints J. Michael Shepherd to Board
-
Progenics Pharma (PGNX) Says Data Presented at SNMMI Meeting Highlights Potential of its PSMA-Targeted Imaging Agent, PyL, in Detecting Prostate Cancer
-
Stanford proposes $3.4 billion housing plan in high-cost California area
-
Sutro Biopharma Inc. (STRO) Announces Connie Matsui as Board Chair
-
FICO (FICO) Appoints Michael McLaughlin as CFO
-
Krystal Biotech (KRYS) Reports Positive Results from Phase 2 Clinical Trial of KB103; Granted FDA RMAT Designation for KB103
-
HMS Holdings Corp. (HMSY) Adds Katherine Baicker and Jeffrey Rideout to Board
-
Inspired by NBA, Wie ready to play hurt at Women's PGA Championship
-
Stanford University and Avast research shows that connected devices are now prevalent in two thirds of North American homes, highlighting growing cybersecurity risks
-
Celebrating Nanotechnology at the Hebrew University: Inaugural Dan Maydan Prize for Nanoscience Research Presented to Prof Yi Cui of Stanford
-
Stanford Graduate School of Business Launches Stanford Embark, a New Online Toolkit for Entrepreneurs Across the Globe
-
Genesco (GCO) Names Mel Tucker As New CFO
-
Regulus Therapeutics (RGLS) Appoints Jake Nunn and Simos Simeonidis, Ph.D. to Board
-
Shutterfly (SFLY) Announces Ryan O’Hara President and CFO
-
Tenet Healthcare (THC) Announces Chris Lynch to Board
-
Stanford Health Care and Lucile Packard Children's Hospital Stanford Re-verified as a Level I Trauma Center
-
SurveyMonkey (SVMK) Announces Debbie Clifford as CFO
-
Myriad Genetics (MYGN) Announces New Results from Two Large Studies of Its myRisk Hereditary Cancer Test at ASCO
-
Cavco Industries (CVCO) Announces Julia W. Sze to Board
-
Brainstorm Cell Therapeutics (BCLI) Reports Second Clinical Site to Enroll Patients in Its Progressive MS Phase 2 Study
-
Hemisphere Media (HMTV) Announces Sonia Dula to Board
-
Remark Media (MARK) Announces Dr. Elizabeth Xu to Board
-
Stanford Seed Partners with Entrepreneurs in Africa and India to Catalyze Economic Growth
-
Evertec (EVTC) Announces Ivan Pagan and Aldo Polak to Board
-
Veritone One (VERI) Adds Richard H. Taketa to Board
-
Energy Focus (EFOI) Announces Steve Socolof to Board
-
Shockwave Medical (SWAV) Appoints Keith D. Dawkins M.D. as CMO
-
ESPN (DIS) and Caesars Entertainment (CZR) Announce Pact for Sports Betting Content
-
KBL Merger Corp. (KBLM) Announces Non-Binding Term Sheet to Acquire CannBioRx Life Sciences Corp.
-
TG Therapeutics (TGTX) Announces Long-term Follow-up Data from the Phase 2 Trial of Ublituximab in Patients with Multiple Sclerosis at AAN
-
Stanford Claimholders and Victims of $7 Billion Ponzi Scheme Take Legal Action Against TD Bank, HSBC, and SocGen

